Skip to content
In deliveryUnited KingdomGoodsFramework agreement£592,363,416

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

Awarded to ABBVIE LTD, ACCORD-UK LTD, ALFASIGMA UK LIMITED +26 more

NHS England(buyer)

Published
Published 21 May 2025
Deadline
Closed 26 March 2026

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS England has awarded a framework agreement for branded medicines supply to Tranche B covering London and the South of England, effective 1 September 2026 to 31 August 2028 with optional extensions up to 24 months, with a contract value of £1.67 billion. The award was made on 31 May 2026 to 29 pharmaceutical suppliers including AbbVie, Amgen, Pfizer, Roche, Janssen-Cilag, and others. The framework also includes a separate lot for Ustekinumab covering the North of England and Midlands & East for the period 1 September 2026 to 31 August 2027 with optional 12-month extension.

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Lots (2)

  • Lot 1 - Tranche B for London & South of England

    NHS Branded Medicines - Tranche B for London & South of England

    £813,863,584Won by PFIZER LIMITEDWon by ABBVIE LTDWon by ACCORD-UK LTDWon by ALFASIGMA UK LIMITEDWon by AMGEN LIMITEDWon by AVENTIS PHARMA LIMITED t-a SanofiWon by BIOGEN IDEC LIMITEDWon by BIOSIMILAR COLLABORATIONS IRELAND LIMITEDWon by CELLTRION HEALTHCARE UK LIMITEDWon by DR REDDY'S LABORATORIES (UK) LIMITEDWon by FRESENIUS KABI LIMITEDWon by GEDEON RICHTER (UK) LIMITEDWon by ROCHE PRODUCTS LIMITEDWon by GLAXOSMITHKLINE UK LIMITEDWon by JANSSEN-CILAG LIMITEDWon by MILPHARM LIMITEDWon by ORGANON PHARMA (UK) LIMITEDWon by ORIFARM UK LTDWon by SAMSUNG BIOEPIS UK LIMITEDWon by SANDOZ LIMITEDWon by SWEDISH ORPHAN BIOVITRUM LTDWon by TEVA UK LIMITEDWon by THORNTON & ROSS LIMITEDWon by UCB PHARMA LIMITEDWon by ZENTIVA PHARMA UK LIMITED
  • Lot 2 - Ustekinumab for North of England and Midlands & East

    NHS Branded Medicines - Ustekinumab for North of England and Midlands & East

    £18,903,212Won by AMGEN LIMITEDWon by BIOSIMILAR COLLABORATIONS IRELAND LIMITEDWon by CELLTRION HEALTHCARE UK LIMITEDWon by FRESENIUS KABI LIMITEDWon by GEDEON RICHTER (UK) LIMITEDWon by JANSSEN-CILAG LIMITEDWon by SANDOZ LIMITEDWon by THORNTON & ROSS LIMITEDWon by BIOGEN IDEC LIMITED

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£592,363,416
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
21 May 2025
Questions by
19 March 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£1,665,533,592
Award date
31 May 2026
Contract period
31 August 2026 → 31 August 2028
Winners
  • ABBVIE LTD
  • ACCORD-UK LTD
  • ALFASIGMA UK LIMITED
  • AMGEN LIMITED
  • AVENTIS PHARMA LIMITED
  • AVENTIS PHARMA LIMITED t-a Sanofi
  • Alfasigma UK Limited
  • BIOGEN IDEC LIMITED
  • BIOSIMILAR COLLABORATIONS IRELAND LIMITED
  • Biosimilar Collaborations Ireland Limited
  • CELLTRION HEALTHCARE UK LIMITED
  • CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
  • DR REDDY'S LABORATORIES (UK) LIMITED
  • FRESENIUS KABI LIMITED
  • GEDEON RICHTER (UK) LIMITED
  • GLAXOSMITHKLINE UK LIMITED
  • JANSSEN-CILAG LIMITED
  • MILPHARM LIMITED
  • ORGANON PHARMA (UK) LIMITED
  • ORIFARM UK LTD
  • PFIZER LIMITED
  • ROCHE PRODUCTS LIMITED
  • SAMSUNG BIOEPIS UK LIMITED
  • SANDOZ LIMITED
  • SWEDISH ORPHAN BIOVITRUM LTD
  • TEVA UK LIMITED
  • THORNTON & ROSS LIMITED
  • UCB PHARMA LIMITED
  • ZENTIVA PHARMA UK LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    10 July 2026

  2. Contract

    9 June 2026

  3. Contract Notice

    23 February 2026

  4. Planning Update

    18 February 2026

  5. Prior Information Notice

    14 January 2026

  6. Planning Update

    3 June 2025

  7. Prior Information Notice

    21 May 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.